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Abstract
In this two-years surveillance of 2009 pandemic influenza A (H1N1) (pH1N1) in Guangzhou, China, we reported here that the
scale and duration of pH1N1 outbreaks, severe disease and fatality rates of pH1N1 patients were significantly lower or
shorter in the second epidemic year (May 2010-April 2011) than those in the first epidemic year (May 2009-April 2010)
(P,0.05), but similar to those of seasonal influenza (P.0.05). Similar to seasonal influenza, pre-existing chronic pulmonary
diseases was a risk factor associated with fatal cases of pH1N1 influenza. Different from seasonal influenza, which occurred
in spring/summer seasons annually, pH1N1 influenza mainly occurred in autumn/winter seasons in the first epidemic year,
but prolonged to winter/spring season in the second epidemic year. The information suggests a tendency that the
epidemics of pH1N1 influenza may probably further shift to spring/summer seasons and become a predominant subtype of
seasonal influenza in coming years in Guangzhou, China.
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Introduction
During the spring of 2009, the Centers for Disease Control and
Prevention (CDC) confirmed the first two cases of human infection
with the 2009 pandemic influenza A (H1N1) (pH1N1) virus in the
USA [1,2]. As the virus spread rapidly to other regions of the
world [2,3,4], the World Health Organization (WHO) declared
the first phase VI global influenza pandemic on 11 June 2009. By
25 July 2010, worldwide more than 214 countries and overseas
territories or communities had reported laboratory confirmed
pH1N1 cases, including 18398 deaths [5].
Guangzhou is the largest trading city in southern China with over
7.94 million registered inhabitants and 4.76 million floating
population. Considering that pH1N1 influenza was inevitable to
spread to Guangzhou, we conducted a surveillance system of pH1N1
influenza in early May 2009 in Guangzhou, before the first imported
pH1N1 influenza case (from the US) in China was reported on 18
May 2009. Subsequently, we reported the first confirmed native
pH1N1 case [6], the first outbreak of pH1N1 and the first severe
pH1N1 case [7] in China in May, July and August 2009, respectively.
Although WHO declared that the new H1N1 virus has largely
run its course and the world has been moving into the post-
pandemic period on 10 August 2010 [8], we continued our
surveillance of pH1N1 influenza in Guangzhou and analyzed the
data based on information provided by four general surveillance
hospitals and twelve regional CDC during the two-years
surveillance period from May 2009 to April 2011. Large numbers
of studies/investigations on epidemiology and clinical features of
the first epidemic year of pH1N1 influenza from 2009 to 2010
have been reported [3,9,10,11,12]. However, only little informa-
tion is available for the second epidemic year of pH1N1 influenza
from 2010 to 2011 [13]. In this paper, we described the
information obtained from a two years surveillance of pH1N1
influenza in Guangzhou from May 2009 to April 2011, and
compared with those of traditional seasonal influenza in order to
detect the epidemic tendency of pH1N1 and assist public health
control measures.
Materials and Methods
The protocol of this surveillance was approved by the ethics
committee of Guangzhou Center for Disease Control and Prevention
(GZCDC) and informed consent was obtained from all subjects (or
children’s guardians) recruited to receive a swab or blood test.
Outbreaks of pH1N1 influenza
When the number of fever cases with influenza-like symptoms
increased to over 3 per day or 5 per 3 consecutive days in the same
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of team health care collected basic information and reported to the
regional CDC by telephone or fax. Technical staff in regional
CDC conducted field investigation and verification. Throat swab
samples from at least 10 of these cases were collected and sent to
GZCDC for pH1N1 virus and other influenza virus confirmation
[9]. An outbreak was identified as that at least 15 cases/week were
found in any school, kindergarten or other group. The attack rate
was defined as (Total number of new cases in the observation
period/Number of exposed population at the same period)6100.
The scale was defined as average attack rate/outbreak (%).
Virological surveillance
Four general hospitals and twelve regional CDC, located in 12
districts of Guangzhou City, were selected as the surveillance spots.
Four general hospitals were selected because theyare the four largest
hospitals in the Guangzhou, which located in the center of the city
and and theyare the first choicehospital for the public aftersuffering
from illness. In the day out-patient clinics of these four hospitals, the
patients who appeared body temperature $ 38uC accompanying
with cough or sore throat symptoms were identified as suspected
cases of influenza. Serum and/or swab samples were collected from
these suspected cases for further virological surveillance.
The presence of influenza virus in swab samples was detected by
isolation of the virus in cell cultures and/or real-time RT-PCR,
while antibodies specific to influenza virus were tested by HAI
and/or ELISA, as described previously [8,9,14]. Influenza cases
were confirmed by at least one of positive results of following
laboratory tests: i) isolation of the virus; ii) RNA of influenza virus,
including seasonal H1N1, H3N2, B, and pH1N1; and iii)
seroconversion of influenza specific antibodies.
Severe cases
According to the criteria of Diagnosis and Treatment Guideline for
Influenza issued by China Ministry of Health in 2009, severe cases of
influenza were identified as patients who appeared: i) persistent fever
lasting for . 3 days accompanying with severe cough, ii) purulent
sputum, bloody sputum, or chest pain, iii) respiration frequency
becoming faster, difficult breathing, cyanosis of lips, iv) mind changes,
such as slow, drowsiness, restlessness, convulsions, etc, v) severe
vomiting, diarrhea, dehydration performance, vi) imaging signs of
pneumonia, vii) creatine kinase (CK), creatine kinase-MB (CK-MB)
and/or other enzyme levels increased rapidly, viii) the conditions of
original underlying diseases were significantly worse.
Data analysis
Data were analyzed using SPSS statistical software (version 11.5,
SPSS, Inc., Chicago, IL). x
2 test and/or Fisher exact test were/was
used to compare proportions of different groups. T test was used to
compare the difference between the groups. Binary logistic regression
was employed to explore risk factors potentially associated with fatal
pH1N1 cases, of which different pre-existing chronic diseases were
considered as the independent variables. The progressions of severe
pH1N1 cases were considered as the dependent variation, with 0 for
recovered developing into mild pH1N1 patients and 1 for dead
patients. For all analysis, P values # 0.05 were regarded as significant.
Results
Outbreaks of pH1N1 influenza in Guangzhou
As shown in Table 1, a total of 208 pH1N1 outbreaks were
reported from May 2009 to April 2011. Most outbreaks (205/208,
98.6%) occurred in the first epidemic year from May 2009 to April
2010, whereas only 3 outbreaks (1.4%) were found in the second
epidemic year from May 2010 to April 2011. The frequency of
outbreaks (average number of pH1N1 outbreaks/month) in the
second epidemic year was 0.25, which was significantly lower than
that (17.08) in the first epidemic year (P,0.05). The scale (average
attack rate/outbreak) and duration (average days/outbreak) of
pH1N1 influenza in the second epidemic year were 2.13% and
18.57 days, respectively, which were significantly lower or shorter
than those (9.82% and 26.48 days) in the first epidemic year
(P,0.05). However, the frequency, scale and duration of pH1N1
influenza outbreaks in the second epidemic year were similar to
those of seasonal influenza outbreaks (P.0.05), suggesting that
pH1N1 influenza had most likely become a seasonal influenza in
the second epidemic year in Guangzhou.
Severe and fatal cases of pH1N1 influenza
A total of 81 severe pH1N1 cases were reported during the
surveillance period, of which 16 died. As shown in Fig 1, in the
first epidemic year, the severe disease rate (% of patients
progressed to severe disease) and fatality rate (deaths/10000) in
pH1N1 influenza patients were 0.37% (77/20885) and 7.18 per
10000 (15/20885), respectively, whereas both decreased to 0.02%
(4/17188) and 0.58 per 10000 (1/17188) in the second epidemic
year. Both were significantly lower than those of pH1N1 influenza
in the first epidemic year (P,0.05), but similar to those of seasonal
influenza during the same period (P.0.05). Fatal cases and severe
appeared in each age group ranging from 1 to 71 years old. In age
groups of 0,5, 6,15, 16,25, 26,40, 41,59 and 60, years, the
fatal cases /severe cases/total cases were 6/27/2565, 1/6/18084,
3/14/11716, 2/13/3793, 4/17/1686, 0/4/229, respectively. The
death rate of severe cases did not show significant difference
between these age groups (P.0.05). Also, no pregnant patients
were found in severe and fatal cases (data not shown). More than
Table 1. The frequency, scale and duration of outbreaks of influenza in the first and second epidemic year.
1
st epidemic year 2
ndepidemic year (a) vs (b) P (c) vs (b) P
pH1N1 (a) pH1N1 (b) Seasonal (c)
Frequency* 17.08 (205/12) 0.25 (3/12) 0.25 (3/12) ,0.05 1.00
Scale
& 9.82 (31025/316029) 2.13 (19/890) 2.06 (602/29171) ,0.05 0.88
Duration
# 26.4867.11 18.5765.77 14.0062.00 ,0.05 0.19
*Average number of outbreaks/month.
&Average attck rate/outbreak (%).
#Average days/outbreak6SD.
doi:10.1371/journal.pone.0028027.t001
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chronic disease. Potential risk factors of pre-existing chronic
diseases associated with death were further analyzed using
univariate analysis based on 77 severe cases reported in the first
epidemic years (Table 2). The results showed that chronic
pulmonary diseases were the risk factor associated with the death
of severe pH1N1 influenza (OR=6.00, 95%CI=1.70–21.22),
whereas no other chronic diseases were found to be associated
with the death. In the 2
nd epidemic year, only 4 pH1N1 severe
cases were reported and one of them dead and the fatal case also
had pre-existing chronic pulmonary disease.
Seasonal distribution of pH1N1 influenza in Guangzhou
As shown in Figure 2A, in the first epidemic year, the epidemic
of pH1N1 influenza started at June 2009 and lasted to April 2010,
but mainly occurred in autumn/winter season from October to
December and peaked in November 2009. In the second epidemic
year, the major epidemic of pH1N1 influenza occurred in winter/
spring seasons from January to April 2011 and peaked in March.
Compared to seasonal influenza, which occurred in spring (B
subtype) and summer (H1N1 and H3N2 subtypes) seasons
(Figure 1B), epidemics of pH1N1 influenza seems to occur
preferably in cold seasons. It should be noted, however, that the
peak of pH1N1 epidemic had prolonged from November 2009 in
the first epidemic year to March 2011 in the second epidemic year,
suggesting a tendency that season of pH1N1 influenza epidemic
may probably further shift to spring/summer seasons. Interesting-
ly, seasonal influenza H1N1 virus was a predominant subtype
resulting in the epidemic of influenza in the pre-epidemic year
from May to August 2008, but became a subordinate subtype of
epidemic of seasonal influenza in summer of 2009 and
disappeared completely thereafter. Instead, pN1N1 virus, as a
subordinate subtype, was co-circulating with seasonal influenza
H3N2 virus in summer season. The information suggested that
pH1N1 will probably replace the traditional seasonal influenza
H1N1 and result in seasonal influenza in coming years in
Guangzhou.
Discussion
At the early stage of pH1N1 influenza spread to Guangzhou
(May to June 2009), only a few persons acquired the infection
(Fig. 2A), which might be attributed to the strict measures applied
in Guangzhou for the control of this infectious disease. However,
similar to the other countries and regions [15,16], pH1N1
influenza virus was spread to the whole city and resulted in large
number of outbreaks in the first epidemic year after August 2009
(Table 1), which is markedly higher than previous outbreaks of
seasonal influenza in Guangzhou [17]. Consistently, the frequen-
cy, scale and duration of the outbreaks of pH1N1 influenza were
significantly higher or longer than that of seasonal influenza, as we
reported previously, in a boarding school the infection rate was
32% [18]. This might be due to the fact that pH1N1 virus was
newly derived originally from swine and there was no or little
immunity against the infection caused by this virus in the
Figure 1. Severe disease and fatality rates of pH1N1 and seasonal influenza in Guangzhou. (A) Severe disease rate (% of patients
progressed to severe disease) of pH1N1 influenza in the first (1st pH1N1) and second (2nd pH1N1) epidemic year and of seasonal influenza in the
second epidemic year (2nd seasonal). (B) Fatality rate (deaths/10000) of pH1N1 influenza in the first (1st pH1N1) and second (2nd pH1N1) epidemic
year and of seasonal influenza in the second year (2nd seasonal).
doi:10.1371/journal.pone.0028027.g001
Table 2. Univariate analysis of potential risk factors
associated with the death of pH1N1 influenza severe cases in
the first epidemic year.*
Factors Into mild
Into
death OR
# 95%CI
+ 2 + 2
Chronic lung disease 7 54 7 9 6.00 1.70–21.22
Cardiovascular disease 7 54 3 13 1.78 0.40–7.83
Malignant tumor 1 60 2 14 8.57 0.73–101.04
Chronic renal disease 0 61 1 15 1.07 0.94–1.21
Nervous system disease 1 60 1 15 4.00 0.20–67.71
Immune system disease 1 60 1 15 4.00 0.20–67.71
Metabolism system
disease
2 59 0 16 0.97 0.92–1.01
Hematological system
Disease
1 60 1 15 4.00 0.20–67.71
*Four pH1N1 sever cases were reported in the second epidemic year with one
death and the dead case also had pre-existing chronic pulmonary disease.
#OR=odds ratio.
doi:10.1371/journal.pone.0028027.t002
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$ 60 years was only accounted for 0.60% of the total pH1N1
confirmed cases, which was similar to many other countries, such
as the United States and England where less cases among people
over 60 was also observed [19,20], which needs further study.
Similar to other reports [15,16,21,22,23,24], in Guangzhou,
severe disease and fatality rates of pH1N1 influenza in the first
epidemic year were significantly higher than those of seasonal
influenza (Fig. 1), but significantly lower than the initial epidemic
estimate [25]. However, it is different from previous reports that
age, pregnancy, diabetes and obesity might be risk factors
associated with severe and fatal cases of pHN1 influenza
[26,27,28,29,30,31], our results did not show significant associa-
tion between these factors and severe/fatal cases of pH1N1 in
Guangzhou (Table 2). Nevertheless, our results showed that, over
half of severe cases had pre-existing chronic diseases, of which
chronic pulmonary and cardiovascular diseases were more
common, and only chronic pulmonary disease was the risk factor
associated with the death of severe pH1N1 influenza. This is
consistent with previous studies on seasonal influenza and some
recent studies on pH1N1 influenza [26,32,33]. Our surveillance
showed that features of pH1N1 influenza in the second epidemic
year had been changed as follows: (1) Outbreaks of pH1N1
influenza reduced significantly from 205 in the first epidemic year
to 3 in the second epidemic year. (2) The frequency, scale and
duration of pH1N1 outbreaks in the second epidemic year were
significantly lower or shorter than those in the first epidemic year.
(3) Severe disease and fatality rates of pH1N1 influenza in the
second epidemic year were significantly lower than those in the
first epidemic year. These features of pH1N1 influenza in the
second epidemic year are similar to those of seasonal influenza but
significantly different from those of pH1N1 influenza in the first
year. These changes of pH1N1 influenza in the second epidemic
year may probably be attributed to part of the population in
Guangzhou had experienced pH1N1 influenza in the first
epidemic year or received pH1N1 influenza vaccination which
was started in Guangzhou from October 2009 [34]. Although it
has been reported that vaccination of 2009 pH1N1 influenza was
effective [35], it has been reported that some persons were still
infected by pH1N1 virus after they received the vaccination [34].
This may be due to: (1) as we have reported, over half of recovered
patients and vaccinated persons would have lost sufficient
immunity against the recurrence of the viral infection after half
a year (17); and (2) influenza virus genome can mutate rapidly to
escape the host immunity. Recently, similar changes in pH1N1
influenza epidemics are also reported by other groups [36].
Therefore, we may conclude that pH1N1 no longer caused a
pandemic after the first epidemic year and had likely become a
seasonal influenza in Guangzhou, China.
Our results also showed that, in Guangzhou, seasonal influenza
occurred in spring (B subtype) and summer (H1N1 and/or H3N2
subtypes) seasons annually, whereas pH1N1 influenza mainly
occurred in autumn/winter seasons from October to December
2009 in the first epidemic year (Fig. 2). The different seasonal
Figure 2. Seasonal distribution of influenza in Guangzhou from May 2008 to April 2011. (A) Confirmed cases of seasonal influenza
(Seasonal, including H1N1, H3N2 and B) and pH1N1 influenza are shown in the indicated time. (B) Confirmed cases of seasonal influenza caused by
subtypes H1N1, H3N2 and B are shown in the indicated time.
doi:10.1371/journal.pone.0028027.g002
Surveillance of 2009 Pandemic Influenza A (H1N1)
PLoS ONE | www.plosone.org 4 November 2011 | Volume 6 | Issue 11 | e28027distribution of seasonal influenza and pH1N1 influenza has also
been reported by other studies [37,38]. Notably we found that the
epidemic of pH1N1 influenza had prolonged to winter/spring
season from January to March 2011 in the second epidemic year,
showing a tendency that the epidemics of pH1N1 influenza may
probably further shift to spring/summer seasons (Fig. 2A). It is also
noted that seasonal influenza H1N1 virus caused the epidemic of
influenza in 2008, whereas H3N2 influenza became to be
predominant in 2009 and 2010 accompanied with disappearance
of seasonal influenza H1N1 after winter season of 2009.
Taken together, the information has suggested that pH1N1
influenza virus may probably replace the traditional seasonal
influenza H1N1 resulting in seasonal influenza in coming years in
Guangzhou. However, it is needed to be further confirmed in
future years. Thus, we will continue our surveillance of pH1N1,
practically in virological surveillance to monitor potential possible
virus variations due to the viral gene mutations and reassortments.
Acknowledgments
All enrollees participating in the surveillance are appreciated.
Our special thanks to the public unit coordinators and nurses in
influenza surveillance hospitals in Guangzhou.
Author Contributions
Conceived and designed the experiments: MW K-yC TL CF. Performed
the experiments: BD M-fL JW YC EL JG. Analyzed the data: WH ZD B-
JZ. Contributed reagents/materials/analysis tools: ZY YW ML JL. Wrote
the paper: TL CF BD JW.
References
1. (2009) Swine influenza A (H1N1) infection in two children–Southern California,
March-April 2009. MMWR Morb Mortal Wkly Rep 58: 400–402.
2. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, et al. (2009) Emergence
of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360:
2605–2615.
3. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, et al. (2009)
Hospitalized patients with 2009 H1N1 influenza in the United States, April-June
2009. N Engl J Med 361: 1935–1944.
4. (2009) New influenza A (H1N1) virus: global epidemiological situation, June
2009. Wkly Epidemiol Rec 84: 249–257.
5. WHO website. Available: http://www.who.int/csr/don/2010_07_30/en/in
dex.html. Accessed 2010 July, 30.
6. Yuan J, Li MX, Liu YF, Di B, Xiao XL, et al. (2009) [Investigation on a seasonal
influenza accompanying with the first locale novel A/H1N1 influenza outbreak
in China]. Zhonghua Yu Fang Yi Xue Za Zhi 43: 852–855.
7. Yang ZC, Li TG, Liu YF, Wu XW, Yuan J, et al. (2009) [Epidemiological
characteristic of first case of locally identified A/H1N1 secondary cases caused
by imported source of infection in China]. Zhonghua Liu Xing Bing Xue Za Zhi
30: 684–686.
8. WHO website. Available: http://www.who.int/mediacentre/news/statements/
2010/h1n1_vpc_20100810/en/index.html. Accessed 2010 August, 10.
9. CDC CFDC (2011) Self-reported influenza-like illness during the 2009 H1N1
influenza pandemic–United States, September 2009 - March 2010. MMWR
Morb Mortal Wkly Rep 60: 37–41.
10. Dominguez-Cherit G, Namendys-Silva SA, de la Torre A, Macias AE, Cordova-
Villalobos JA (2010) H1N1 Influenza Pandemic of 2009 Compared With Other
Influenza Pandemics: Epidemiology, Diagnosis, Management, Pulmonary
Complications, and Outcomes. Curr Infect Dis Rep 12: 204–210.
11. Lindblade KA, Arvelo W, Gray J, Estevez A, Frenkel G, et al. (2010) A
comparison of the epidemiology and clinical presentation of seasonal influenza A
and 2009 pandemic influenza A (H1N1) in Guatemala. PLoS One 5: e15826.
12. Wilking H, Buda S, von der Lippe E, Altmann D, Krause G, et al. (2010)
Mortality of 2009 pandemic influenza A(H1N1) in Germany. Euro Surveill 15.
13. Bandaranayake D, Jacobs M, Baker M, Hunt D, Wood T, et al. (2011) The
second wave of 2009 pandemic influenza A(H1N1) in New Zealand, January-
October 2010. Euro Surveill 16.
14. Wang M, Yuan J, Li T, Liu Y, Wu J, et al. (2011) Antibody Dynamics of 2009
Influenza A (H1N1) Virus in Infected Patients and Vaccinated People in China.
PLoS One 6: e16809.
15. Hersh AL, Herigon JC, Ampofo K, Pavia AT, Newland JG (2011) Rapid
Increase in Use of Antiviral Therapy for Hospitalized Children with Influenza
During the 2009 H1N1 Epidemic. Pediatr Infect Dis J.
16. Roll U, Yaari R, Katriel G, Barnea O, Stone L, et al. (2011) Onset of a
pandemic: characterizing the initial phase of the swine flu (H1N1) epidemic in
Israel. BMC Infect Dis 11: 92.
17. Li T, Liu W, Yang Z, Liu Y, Wang Y, et al. (2008) Surveillance analysis of
influenza in Guangzhou ,2006. Disease surveillance 23: 478–480.
18. Li T, Liu Y, Di B, Wang M, Shen J, et al. (2011) Epidemiological investigation of
an outbreak of pandemic influenza A (H1N1) 2009 in a boarding school:
Serological analysis of 1570 cases. J Clin Virol 50: 235–239.
19. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, et al. (2009) Cross-reactive
antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med
361: 1945–1952.
20. Miller E, Hoschler K, Hardelid P, Stanford E, et al. (2010) Incidence of 2009
pandemic influenza A H1N1infection in England: a cross-sectional serological
study.Lancet. 375: 1100–1108.
21. Baker MG, Wilson N, Huang QS, Paine S, Lopez L, et al. (2009) Pandemic
influenza A(H1N1)v in New Zealand: the experience from April to August 2009.
Euro Surveill 14.
22. Donaldson LJ, Rutter PD, Ellis BM, Greaves FE, Mytton OT, et al. (2009)
Mortality from pandemic A/H1N1 2009 influenza in England: public health
surveillance study. BMJ 339: b5213.
23. Simon ML, de Mateo OS, Larrauri CA, Jimenez-Jorge S, Vaque RJ, et al.
(2011) [Transmissibility and severity of the pandemic influenza A (H1N1) 2009
virus in Spain.]. Gac Sanit.
24. Torres JP, O’Ryan M, Herve B, Espinoza R, Acuna G, et al. (2010) Impact of
the novel influenza A (H1N1) during the 2009 autumn-winter season in a large
hospital setting in Santiago, Chile. Clin Infect Dis 50: 860–868.
25. Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD, et al.
(2009) Pandemic potential of a strain of influenza A (H1N1): early findings.
Science 324: 1557–1561.
26. Kirakli C, Tatar D, Cimen P, Edipoglu O, Coskun M, et al. (2011) Survival
From Severe Pandemic H1N1 in Urban and Rural Turkey: A Case Series.
Respir Care.
27. Nickel KB, Marsden-Haug N, Lofy KH, Turnberg WL, Rietberg K, et al. (2011)
Age as an independent risk factor for intensive care unit admission or death due
to 2009 pandemic influenza A (H1N1) virus infection. Public Health Rep 126:
349–353.
28. Oh WS, Lee SJ, Lee CS, Hur JA, Hur AC, et al. (2011) A Prediction Rule to
Identify Severe Cases among Adult Patients Hospitalized with Pandemic
Influenza A (H1N1) 2009. J Korean Med Sci 26: 499–506.
29. Reyes S, Montull B, Martinez R, Cordoba J, Molina JM, et al. (2011) Risk
factors of A/H1N1 etiology in pneumonia and its impact on mortality. Respir
Med.
30. Vaillant L, La Ruche G, Tarantola A, Barboza P (2009) Epidemiology of fatal
cases associated with pandemic H1N1 influenza 2009. Euro Surveill 14.
31. Webb SA, Pettila V, Seppelt I, Bellomo R, Bailey M, et al. (2009) Critical care
services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med
361: 1925–1934.
32. Pebody RG, McLean E, Zhao H, Cleary P, Bracebridge S, et al. (2010)
Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: risk
factors for death, April 2009 to March 2010. Euro Surveill 15.
33. Kim HS, Kim JH, Shin SY, Kang YA, Lee HG, et al. (2011) Fatal cases of 2009
pandemic influenza A (H1N1) in Korea. J Korean Med Sci 26: 22–27.
34. Fu C (2010) Effectiveness of H1N1 vaccine against reported Influenza A (H1N1):
Southern China, October 2009-February 2010. Hum Vaccin 6.
35. Girard MP, Tam JS, Assossou OM, Kieny MP (2010) The 2009 A (H1N1)
influenza virus pandemic: A review. Vaccine 28: 4895–4902.
36. Louie JK, Jean C, Acosta M, Samuel MC, Matyas BT, et al. (2011) A Review of
Adult Mortality Due to 2009 Pandemic (H1N1) Influenza A in California. PLoS
One 6: e18221.
37. Brammer L, Blanton L, Epperson S, Mustaquim D, Bishop A, et al. (2011)
Surveillance for influenza during the 2009 influenza A (H1N1) pandemic-United
States, April 2009-March 2010. Clin Infect Dis 52 Suppl 1: S27–S35.
38. Haddock RL, Damian YS, Duguies LA, Paulino YC (2010) Guam’s influenza
epidemic(s) of 2009. Hawaii Med J 69: 50–51.
Surveillance of 2009 Pandemic Influenza A (H1N1)
PLoS ONE | www.plosone.org 5 November 2011 | Volume 6 | Issue 11 | e28027